Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

VIJAYA DIAGNOSTIC CENTRE LTD.

NSE : VIJAYABSE : 543350ISIN CODE : INE043W01024Industry : Hospital & Healthcare ServicesHouse : Private

BSE1020.0517.05 (+1.7 %)

PREV CLOSE ( ) 1003.00

OPEN PRICE ( ) 1000.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 9387

TODAY'S LOW / HIGH ( )993.70 1025.85

52 WK LOW / HIGH ( )725.4 1276.75

NSE1020.5017.35 (+1.73 %)

PREV CLOSE( ) 1003.15

OPEN PRICE ( ) 1003.15

BID PRICE (QTY) 1020.50 (472)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 228032

TODAY'S LOW / HIGH( ) 993.15 1026.00

52 WK LOW / HIGH ( )740 1275

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 05-06 2002

Management Info

S Surendranath Reddy - Chairman Suprita Reddy Sura - Managing Director

Registered Office

Address 6-3-883/ F , F P A Building,Near Topaz Building,Punjagutta,
Hyderabad,
Telangana-500082

Phone 040 2342 0411-12

Email info@vijayadiagnostic.com

Website www.vijayadiagnostic.com

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

13May Vijaya Diagnostic Centre informs about
Vijaya Diagnostic Centre has informed that the officials of the Company..

28Apr Vijaya Diagnostic Centre informs about
With refer to letter dated March 25, 2025 wherein the Company had submit..

20Feb Vijaya Diagnostic Centre informs abo
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..

18Feb Vijaya Diagnostic Centre informs about
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..

10Feb Vijaya Diagnostic Centre informs about
Vijaya Diagnostic Centre has informed that the officials of the Company..

Financials

Rs. in Millions

	QTR Mar 25	ANNUAL 25
Net Profit	331.17	1350.12
Gross Profit	451.14	1813.02
Operating Profit	698.3	2718.1
Net Sales	1598.52	6271.38

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Kovai Medical Center (BSE) 6130.35 (3.04%)	M.Cap ( in Cr)6707.99
Dr. Lal Pathlabs (BSE) 2849.45 (3.44%)	M.Cap ( in Cr)23871.41
Metropolis Health. (BSE) 1773.90 (2.24%)	M.Cap ( in Cr)9189.14
Jupiter Life Line (BSE) 1508.90 (1.27%)	M.Cap ( in Cr)9893.26
HealthcareGlobal (BSE) 566.40 (3.41%)	M.Cap ( in Cr)7896.49

Shareholding Pattern

	PROMOTERS	53.05%
	MUTUAL FUNDS/UTI	23.67%
	NON-INSTITUTION	3.87%
	FI/BANKS/INSURANCE	0.01%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Nippon India Pharma...	3.53
DSP Healthcare Fund...	3.40
Kotak Small Cap Fund(G)	3.15
Kotak Business Cycl...	2.95
Bank of India Small...	2.64
HDFC Pharma and Hea...	2.63
Motilal Oswal Small...	2.54

Risk Disclosures on Derivatives

Smart Quotes

VIJAYA DIAGNOSTIC CENTRE LTD.